Publications

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

 5
Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

Tags:

Previous Article

Immunotherapy for difficult-to-treat brain tumors with gut microbiota

Next Article

Role of plasmin in metastatic tumors

Related Posts

Immune evasion through mitochondrial transfer in the tumour microenvironment

Immune evasion through mitochondrial transfer in the tu...

 110

Nuclear morphometrics coupled with machine learning identifies dynamic states of senescence across age

Nuclear morphometrics coupled with machine learning ide...

 15

Palmitoylation of ULK1 by ZDHHC13 plays a crucial role in autophagy

Palmitoylation of ULK1 by ZDHHC13 plays a crucial role ...

 46